Neuropsychiatric Manifest. of SLE:Diagnosis, Clinical Spectrum, & Relationship to Other Features of the Disease
Medicine 55:323, Feinglass,E.J.,et al, 1976
Clinicopath Conf
Tangier Disease, Case 16-1996, NEJM 334:1389-1394996., , 1996
Lymphomatoid Granulomatosis
Human Pathology 3:457, Liebow,A.,et al, 1972
Tumefactive Multiple Sclerosis Lesions under Fingolimod Treatment
Neurol 79:2000-2002,1942, Visser, F.,et al, 2012
Sjogren Syndrome
emedicine.medscape.com,Oct, Miller,A.V., 2011
Intravascular Lymphoma Masquerading as Multiembolic Stroke Developing After Coronary Artery By-Pass Surgery
The Neurologist 15:98-101, Sumer,M.,et al, 2009
The Neurologic Manifestations of Systemic Lupus Erythematosus
The Neurologist 15:115-121, Greenberg,B.M., 2009
Acute Pan-Dysautonomia as well as Central Nervous System Involvement and Peripheral Neuropathies in a Patient with Systemic Lupus Erythematosus
Med Rheumatol 18:516-521, Yukawa, S.,et al, 2008
Treatment of Early Onset Multiple Sclerosis With Subcutaneous Interferon Beta-1a
Neurol 64:888-890, 778, Pohl,D., et al, 2005
Mitoxantrone Treatment of Multiple Sclerosis
Neurol 63(Suppl 6):S28-S32, Cohen,B.A. &Mikol,D.D., 2004
Disease-Modifying Therapy in Multiple Sclerosis: Strategies for Optimizing Management
The Neurologist 8:227-236, Frohman,E.,et al, 2002
Immune Cytopenias as the Presenting Finding in Primary Sjogrens Syndrome
QJM 93:825-829, Schattner,A.,et al, 2000
Multiple Sclerosis, Side Effects of Interferon Beta Therapy and Their Management
Neurol 53:1622-1627, Walther,E.U.&Hohlfeld,R., 1999
Acute Demyelinating Polyneuropathy with Arsenic Ingestion
Muscle & Nerve 19:1611-1613996., Greenberg,S.A., 1996
Chronic Systemic High-Dose Recombinant Interferon Alfa-2a Reduces Exacerbation Rate & MRI Signs in MS
Neurol 44:406-413, Durelli,L.,et al, 1994
Acute Arsenic Intoxication Presenting as Guillain-Barre-Like Syndrome:Donofrio
P. D. , et al, Muscle & Nerve 10:114-120, , 1987
The Natural History of SLE by Prospective Analysis
Medicine 50:85, Estes,D.,et al, 1971